[논문]
1. Lee SI, Kim WY, Kim DK, Suh GY, Kim J, Kim HY, Choi NJ, Jhang WK, Kwak SH, Hong SB. Burnout among intensivists and critical care fellows in South Korea: Current status and associated factors. PLoS One. 2025; 20: e0318495.
2. You SH, Baek MS, Kim TW, Jung SY, Kim WY. Baricitinib therapy in critical COVID-19: plenty of promise, but no hard evidence yet. Crit Care. 2024; 28: 409.
3. You SH, Baek MS, Kim TW, Jung SY, Kim WY. Baricitinib versus tocilizumab in mechanically ventilated patients with COVID-19: a nationwide cohort study. Crit Care. 2024; 28: 282.
4. Kim WY, Jung SY, Kim JY, Chae G, Kim J, Joh JS, Park TY, Baek AR, Jegal Y, Chung CR, Lee J, Cho YJ, Park JH, Hwang JH, Song JW. ECMO is associated with decreased hospital mortality in COVID‑19 ARDS. Sci Rep. 2024; 14: 14835.
5. Kim TW, Kim WY, Park S, Lee SH, Park O, Kim T, Yeo HJ, Jang JH, Cho WH, Huh JW, Lee SM, Chung CR, Lee J, Kim JS, Lim SY, Baek AR, Yoo JW, Kim HC, Choi EY, Park C, Kim TO, Moon DS, Lee SI, Moon JY, Kwon SJ, Seong GM, Jung WJ, Baek MS. Risk Factors for the Mortality of Patients With Coronavirus Disease 2019 Requiring Extracorporeal Membrane Oxygenation in a Non-Centralized Setting: A Nationwide Study. J Korean Med Sci. 2024; 39: e75.
6. Lee MT, Baek MS, Kim TW, Jung SY, Kim WY. Cardiovascular outcomes between COVID-19 and non-COVID-19 pneumonia: a nationwide cohort study. BMC Med. 2023; 21: 394.
7. You SH, Kweon OJ, Jung SY, Baek MS, Kim WY. Patterns of inflammatory immune responses in patients with septic shock receiving vitamin C, hydrocortisone, and thiamine: clustering analysis in Korea. Acute Crit Care. 2023; 38: 286-297.
8. Kwon KE, Jung SY, Baek MS, Kim WY. Corticosteroids in H1N1, non-viral, and COVID-19 ARDS. Intensive Care Med. 2022; 48: 1809-1811.
9. Kim WY. Multi-omic approach to identify risk markers specific to COVID-19. EBioMedicine. 2022; 79: 104009.
10. Lee HJ, Kim OH, Baek MS, Kim WY. Vitamin C for septic shock in previous randomized trials: implications of erroneous dosing, timing, and duration. Crit Care. 2022; 26: 61.
11. Lee BY, Lee SI, Baek MS, Baek AR, Na YS, Kim JH, Seong GM, Kim WY. Lower Driving Pressure and Neuromuscular Blocker Use Are Associated With Decreased Mortality in Patients With COVID-19 ARDS. Respir Care. 2022; 67: 216-226.
12. Jung SY, Lee MT, Baek MS, Kim WY. Vitamin C for ≥ 5 days is associated with decreased hospital mortality in sepsis subgroups: a nationwide cohort study. Crit Care. 2022; 26: 3.
13. Kweon OJ, Cha MJ, Baek MS, Choi SH, Kim WY. Biomarkers Associated with Failure of Liberation from Oxygen Therapy in Severe COVID-19: A Pilot Study. J Pers Med. 2021; 11: 974.
14. Kim WY, Kweon OJ, Cha MJ, Baek MS, Choi SH. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study. PLoS One. 2021; 16: e0254167.
15. Choi JC, Kim WY. Inhaled budesonide for early treatment of COVID-19. Lancet Respir Med. 2021; 9: e60.
16. Lee MT, Jung SY, Baek MS, Shin J, Kim WY. Early Vitamin C, Hydrocortisone, and Thiamine Treatment for Septic Cardiomyopathy: A Propensity Score Analysis. J Pers Med. 2021; 11: 610.
17. Jung SY, Choi JC, You SH, Kim WY. Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study. Clin Infect Dis. 2020; 71: 2121-2128.
18. Choi JC, Jung SY, Yoon UA, You SH, Kim MS, Baek MS, Jung JW, Kim WY. Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study. J Clin Med. 2020; 9: 3406.
19. Lee HJ, Kim WY. Mesenchymal stromal cell application as an emerging translational medicine for acute respiratory distress syndrome. Ann Transl Med. 2020; 8: 267.
20. Kim WY, Park MJ, Rhee CK, Lee SY, Kim DJ, Kim DG, Choi CM, Kim DK, Kim YH, Yoon HJ, Kim JY. HL301 versus Umckamin in the treatment of acute bronchitis: a phase III, randomized, controlled, double-blind, multicenter study. Curr Med Res Opin. 2020; 36: 503-508.
[저서]
1. 고윤석, 김원영, 남경훈, 서희정, 오동규, 임채만, 허진원, 홍석경, 김민석, 김은영, 서가진, 안지환, 이승주, 장민경, 홍상범. 실전 기계환기법. 군자출판사. 2021.